Regional	O
knockdown	O
of	O
NDUFS4	B-GP
implicates	O
a	O
thalamocortical	O
circuit	O
mediating	O
anesthetic	O
sensitivity	O

Competing	O
Interests	O
:	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Knockout	O
of	O
the	O
mitochondrial	B-GP
complex	I-GP
I	I-GP
protein	O
,	O
NDUFS4	B-GP
,	O
profoundly	O
increases	O
sensitivity	O
of	O
mice	B-OG
to	O
volatile	O
anesthetics	O
.	O

In	O
mice	B-OG
carrying	O
an	O
Ndufs4lox	O
/	O
lox	O
gene	O
,	O
adeno	B-OG
-	I-OG
associated	I-OG
virus	I-OG
expressing	O
Cre	B-GP
recombinase	I-GP
was	O
injected	O
into	O
regions	O
of	O
the	O
brain	O
postulated	O
to	O
affect	O
sensitivity	O
to	O
volatile	O
anesthetics	O
.	O

These	O
injections	O
generated	O
otherwise	O
phenotypically	O
wild	O
type	O
mice	B-OG
with	O
region	O
-	O
specific	O
,	O
postnatal	O
inactivation	O
of	O
Ndufs4	B-GP
,	O
minimizing	O
developmental	O
effects	O
of	O
gene	O
loss	O
.	O

Sensitivities	O
to	O
the	O
volatile	O
anesthetics	O
isoflurane	O
and	O
halothane	O
were	O
measured	O
using	O
loss	O
of	O
righting	O
reflex	O
(	O
LORR	O
)	O
and	O
movement	O
in	O
response	O
to	O
tail	O
clamp	O
(	O
TC	O
)	O
as	O
endpoints	O
.	O

Knockdown	O
(	O
KD	O
)	O
of	O
Ndufs4	B-GP
in	O
the	O
vestibular	O
nucleus	O
produced	O
resistance	O
to	O
both	O
anesthetics	O
for	O
movement	O
in	O
response	O
to	O
TC	O
.	O
Ndufs4	B-GP
loss	O
in	O
the	O
central	O
and	O
dorsal	O
medial	O
thalami	O
and	O
in	O
the	O
parietal	O
association	O
cortex	O
increased	O
anesthetic	O
sensitivity	O
to	O
both	O
TC	O
and	O
LORR	O
.	O

Knockdown	O
of	O
Ndufs4	B-GP
only	O
in	O
the	O
parietal	O
association	O
cortex	O
produced	O
striking	O
hypersensitivity	O
for	O
both	O
endpoints	O
,	O
and	O
accounted	O
for	O
half	O
the	O
total	O
change	O
seen	O
in	O
the	O
global	O
KO	O
(	O
Ndufs4	B-GP
(	O
KO	O
)).	O

Excitatory	O
synaptic	O
transmission	O
in	O
the	O
parietal	O
association	O
cortex	O
in	O
slices	O
from	O
Ndufs4	B-GP
(	O
KO	O
)	O
animals	B-OG
was	O
hypersensitive	O
to	O
isoflurane	O
compared	O
to	O
control	O
slices	O
.	O

We	O
identified	O
a	O
direct	O
neural	O
circuit	O
between	O
the	O
parietal	O
association	O
cortex	O
and	O
the	O
central	O
thalamus	O
,	O
consistent	O
with	O
a	O
model	O
in	O
which	O
isoflurane	O
sensitivity	O
is	O
mediated	O
by	O
a	O
thalamic	O
signal	O
relayed	O
through	O
excitatory	O
synapses	O
to	O
the	O
parietal	O
association	O
cortex	O
.	O

We	O
postulate	O
that	O
the	O
thalamocortical	O
circuit	O
is	O
crucial	O
for	O
maintenance	O
of	O
consciousness	O
and	O
is	O
disrupted	O
by	O
the	O
inhibitory	O
effects	O
of	O
isoflurane	O
/	O
halothane	O
on	O
mitochondria	O
.	O

Introduction	O

Anesthesia	O
is	O
a	O
complex	O
phenomenon	O
characterized	O
by	O
amnesia	B-DS
,	O
analgesia	O
,	O
immobility	O
and	O
loss	O
of	O
consciousness	O
.	O

Anesthetic	O
mechanisms	O
are	O
not	O
well	O
understood	O
at	O
several	O
levels	O
of	O
neuronal	O
function	O
.	O

These	O
include	O
the	O
molecular	O
binding	O
targets	O
,	O
the	O
disrupted	O
physiological	O
mechanisms	O
,	O
the	O
brain	O
regions	O
involved	O
,	O
and	O
the	O
altered	O
neuronal	O
circuitry	O
systems	O
.	O

Previous	O
reports	O
have	O
shown	O
that	O
defects	O
in	O
mitochondrial	B-GP
complex	I-GP
I	I-GP
profoundly	O
hypersensitize	O
C	B-OG
.	I-OG
elegans	I-OG
,	O
mice	B-OG
and	O
children	O
to	O
volatile	O
anesthetics	O
[	O
1	O
–	O
3	O
].	O

In	O
addition	O
,	O
complex	B-GP
I	I-GP
function	O
is	O
uniquely	O
sensitive	O
to	O
volatile	O
anesthetics	O
in	O
concentrations	O
that	O
correlate	O
with	O
the	O
whole	O
animal	B-OG
EC50s	O
of	O
the	O
respective	O
species	O
[	O
1	O
,	O
4	O
,	O
5	O
].	O

Mice	B-OG
featuring	O
a	O
global	O
knock	O
out	O
of	O
the	O
mitochondrial	O
protein	O
NDUFS4	B-GP
display	O
biochemically	O
proven	O
complex	B-GP
I	I-GP
specific	O
mitochondrial	O
dysfunction	O
[	O
6	O
–	O
8	O
].	O

This	O
animal	B-OG
,	O
Ndufs4	B-GP
(	O
KO	O
),	O
displays	O
the	O
greatest	O
volatile	O
anesthetic	O
hypersensitivity	O
yet	O
reported	O
for	O
any	O
mammal	B-OG
[	O
3	O
].	O

The	O
sensitivity	O
is	O
recapitulated	O
by	O
glutamate	O
-	O
cell	O
specific	O
KO	O
of	O
the	O
gene	O
in	O
the	O
central	O
nervous	O
system	O
[	O
9	O
].	O

It	O
is	O
well	O
documented	O
that	O
anesthetics	O
lower	O
the	O
cerebral	O
metabolic	O
rate	O
in	O
an	O
agent	O
-	O
and	O
region	O
-	O
specific	O
manner	O
[	O
10	O
–	O
14	O
].	O

However	O
,	O
whether	O
this	O
is	O
a	O
cause	O
or	O
effect	O
of	O
the	O
anesthetized	O
state	O
is	O
controversial	O
[	O
15	O
,	O
16	O
].	O

Changes	O
in	O
anesthetic	O
sensitivity	O
seen	O
in	O
Ndufs4	B-GP
(	O
KO	O
)	O
mice	B-OG
favor	O
the	O
model	O
that	O
a	O
lowered	O
metabolic	O
rate	O
causes	O
the	O
anesthetic	O
state	O
.	O

However	O
,	O
it	O
remains	O
possible	O
that	O
compensatory	O
developmental	O
changes	O
in	O
the	O
constitutive	O
global	O
Ndufs4	B-GP
(	O
KO	O
)	O
may	O
also	O
play	O
a	O
role	O
in	O
determining	O
anesthetic	O
sensitivity	O
.	O

To	O
determine	O
whether	O
the	O
inhibited	O
metabolic	O
state	O
of	O
specific	O
regions	O
of	O
the	O
CNS	O
causes	O
the	O
anesthetic	O
phenotype	O
,	O
and	O
to	O
eliminate	O
early	O
developmental	O
changes	O
resulting	O
from	O
the	O
global	O
loss	O
of	O
Ndufs4	B-GP
,	O
we	O
postnatally	O
knocked	O
down	O
Ndufs4	B-GP
in	O
specific	O
CNS	O
regions	O
in	O
mice	B-OG
with	O
normal	O
volatile	O
anesthetic	O
sensitivity	O
.	O

Taking	O
cues	O
from	O
current	O
literature	O
[	O
17	O
–	O
19	O
]	O
and	O
the	O
pathogenesis	O
of	O
the	O
global	O
KO	O
[	O
20	O
],	O
Ndufs4	B-GP
was	O
separately	O
knocked	O
down	O
in	O
the	O
vestibular	O
nucleus	O
(	O
VN	O
),	O
the	O
mesopontine	O
tegmental	O
area	O
(	O
MPTA	O
),	O
central	O
and	O
dorsal	O
medial	O
thalami	O
(	O
CMT	O
&	O
DMT	O
),	O
and	O
the	O
parietal	O
association	O
cortex	O
(	O
PAC	O
).	O

The	O
contribution	O
of	O
the	O
regional	O
mitochondrial	O
defects	O
on	O
sensitivity	O
to	O
isoflurane	O
(	O
ISO	O
)	O
or	O
halothane	O
(	O
HAL	O
)	O
were	O
evaluated	O
using	O
loss	O
of	O
righting	O
reflex	O
(	O
LORR	O
)	O
and	O
loss	O
of	O
response	O
to	O
a	O
tail	O
clamp	O
(	O
TC	O
)	O
as	O
endpoints	O
.	O

Since	O
loss	O
of	O
the	O
protein	O
NDUFS4	B-GP
in	O
the	O
PAC	O
caused	O
the	O
largest	O
change	O
in	O
ISO	O
and	O
HAL	O
sensitivity	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
NDUFS4	B-GP
loss	O
on	O
the	O
sensitivity	O
of	O
excitatory	O
field	O
potentials	O
to	O
ISO	O
in	O
the	O
PAC	O
.	O

Results	O

We	O
previously	O
reported	O
the	O
striking	O
hypersensitivity	O
of	O
Ndufs4	B-GP
global	O
KO	O
mice	B-OG
to	O
ISO	O
and	O
HAL	O
for	O
the	O
TC	O
assay	O
(	O
S1	O
Table	O
)	O
[	O
3	O
].	O

Here	O
,	O
we	O
measured	O
the	O
change	O
in	O
sensitivity	O
of	O
the	O
global	O
KO	O
for	O
loss	O
of	O
righting	O
reflex	O
(	O
LORR	O
).	O
Ndufs4	B-GP
(	O
KO	O
)	O
mice	B-OG
were	O
hypersensitive	O
to	O
ISO	O
(	O
EC50	O
(	O
control	O
)	O
0	O
.	O
96	O
±	O
0	O
.	O
08	O
%,	O
EC50	O
(	O
KO	O
)	O
0	O
.	O
42	O
±	O
0	O
.	O
08	O
%;	O
p	O
=	O
3	O
.	O
1X10	O
-	O
7	O
)	O
and	O
HAL	O
(	O
EC50	O
(	O
control	O
)	O
0	O
.	O
95	O
±	O
0	O
.	O
03	O
%,	O
EC50	O
(	O
KO	O
)	O
0	O
.	O
41	O
±	O
0	O
.	O
05	O
%;	O
p	O
=	O
1	O
.	O
4X10	O
-	O
10	O
)	O
(	O
S1	O
Table	O
).	O

Active	O
(	O
WT	O
-	O
Cre	B-GP
)	O
and	O
inactive	O
(	O
Δ	O
-	O
Cre	B-GP
)	O
viruses	B-OG
,	O
each	O
linked	O
to	O
a	O
GFP	B-GP
construct	O
to	O
establish	O
localization	O
,	O
were	O
then	O
injected	O
into	O
five	O
regions	O
of	O
the	O
CNS	O
of	O
Ndufs4lox	O
/	O
lox	O
mice	B-OG
(	O
Fig	O
1A	O
and	O
1B	O
).	O

Since	O
the	O
half	O
-	O
life	O
of	O
NDUFS4	B-GP
is	O
around	O
17	O
days	O
[	O
21	O
],	O
we	O
performed	O
behavioral	O
testing	O
and	O
histological	O
analyses	O
three	O
weeks	O
after	O
viral	O
injections	O
.	O

Robust	O
knockdown	O
of	O
Ndufs4	B-GP
in	O
the	O
regions	O
injected	O
with	O
WT	O
-	O
Cre	B-GP
virus	B-OG
was	O
confirmed	O
by	O
immunohistochemistry	O
(	O
Fig	O
1C	O
,	O
S1	O
Fig	O
)	O
at	O
4	O
weeks	O
post	O
virus	B-OG
injections	O
.	O

The	O
loss	O
of	O
NDUFS4	B-GP
immunostaining	O
in	O
the	O
GFP	B-GP
-	O
expressing	O
virus	B-OG
infected	O
cells	O
in	O
the	O
injected	O
regions	O
was	O
quantified	O
to	O
confirm	O
virus	B-OG
mediated	O
knockdown	O
of	O
NDUFS4	B-GP
(	O
Fig	O
1D	O
).	O

We	O
found	O
that	O
cells	O
near	O
the	O
periphery	O
of	O
the	O
WT	O
-	O
Cre	B-GP
injected	O
foci	O
,	O
which	O
did	O
not	O
take	O
up	O
the	O
virus	B-OG
,	O
retained	O
the	O
expression	O
of	O
NDUFS4	B-GP
(	O
S1B	O
Fig	O
).	O

By	O
immunostaining	O
,	O
we	O
found	O
that	O
cytochrome	B-GP
C	I-GP
expression	O
,	O
indicating	O
the	O
presence	O
of	O
mitochondria	O
,	O
remained	O
unaltered	O
in	O
the	O
WT	O
-	O
Cre	B-GP
and	O
Δ	O
-	O
Cre	B-GP
injected	O
regions	O
(	O
S2	O
Fig	O
).	O

Viral	O
injections	O
and	O
characterization	O
.	O

A	O
.	O

Schematic	O
diagram	O
depicting	O
the	O
five	O
regions	O
which	O
were	O
injected	O
with	O
either	O
rAAV	O
/	O
WT	O
-	O
Cre	B-GP
GFP	B-GP
(	O
knockout	O
virus	B-OG
expressing	O
functional	O
Cre	B-GP
recombinase	I-GP
)	O
or	O
rAAV	O
/	O
Δ	O
-	O
Cre	B-GP
GFP	B-GP
(	O
sham	O
virus	B-OG
expressing	O
nonfunctional	O
Cre	B-GP
recombinase	I-GP
).	O
B	O
.	O

Schematic	O
showing	O
the	O
mechanism	O
of	O
gene	O
deletion	O
.	O

Exon	O
2	O
of	O
genomic	O
Ndufs4	B-GP
is	O
excised	O
by	O
the	O
virus	B-OG
expressing	O
active	O
Cre	B-GP
recombinase	I-GP
,	O
resulting	O
in	O
the	O
loss	O
of	O
NDUFS4	B-GP
protein	O
as	O
described	O
by	O
Kruse	O
et	O
al	O
.	O
[	O
6	O
].	O
C	O
.	O

Loss	O
of	O
Ndufs4	B-GP
expression	O
in	O
active	O
Cre	B-GP
virus	B-OG
infected	O
cells	O
in	O
the	O
PAC	O
.	O

Infected	O
cells	O
appear	O
green	O
under	O
the	O
confocal	O
microscope	O
due	O
to	O
the	O
viral	O
GFP	B-GP
co	O
-	O
expression	O
(	O
Magnification	O
X1000	O
).	O

In	O
the	O
Δ	O
-	O
Cre	B-GP
sham	O
virus	B-OG
infected	O
cells	O
of	O
the	O
PAC	O
,	O
mitochondrial	O
NDUFS4	B-GP
fluorescence	O
(	O
red	O
)	O
is	O
seen	O
,	O
which	O
is	O
absent	O
in	O
the	O
WT	O
-	O
Cre	B-GP
infected	O
cells	O
.	O
D	O
.	O

Representative	O
quantitation	O
of	O
NDUFS4	B-GP
expression	O
in	O
the	O
virus	B-OG
infected	O
cells	O
,	O
shown	O
as	O
a	O
percentage	O
of	O
total	O
infected	O
cells	O
.	O

20	O
image	O
fields	O
were	O
quantified	O
per	O
injected	O
locus	O
.	O

Scale	O
bar	O
:	O
10μm	O
.	O
***	O
indicates	O
p	O
-	O
values	O
<	O
0	O
.	O
001	O
.	O

Vestibular	O
nucleus	O
(	O
VN	O
)	O

The	O
VN	O
is	O
one	O
of	O
the	O
regions	O
showing	O
maximal	O
pathology	O
in	O
Ndufs4	B-GP
(	O
KO	O
)	O
animals	B-OG
and	O
is	O
implicated	O
in	O
locomotor	O
ability	O
and	O
nociceptive	O
signaling	O
[	O
22	O
,	O
23	O
].	O

We	O
injected	O
WT	O
-	O
Cre	B-GP
(	O
Fig	O
2A	O
,	O
2B	O
and	O
2C	O
)	O
and	O
Δ	O
-	O
Cre	B-GP
(	O
S3A	O
Fig	O
)	O
bilaterally	O
into	O
the	O
VN	O
.	O

Loss	O
of	O
Ndufs4	B-GP
in	O
the	O
VN	O
decreased	O
sensitivity	O
of	O
the	O
mice	B-OG
and	O
caused	O
resistance	O
to	O
both	O
ISO	O
and	O
HAL	O
for	O
TC	O
(	O
Fig	O
2E	O
,	O
S4B	O
Fig	O
;	O
Table	O
1	O
).	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
the	O
LORR	O
between	O
VN	O
specific	O
KD	O
and	O
control	O
animals	B-OG
for	O
either	O
anesthetic	O
(	O
Fig	O
2D	O
,	O
S4A	O
Fig	O
;	O
Table	O
1	O
).	O

Knockdown	O
of	O
Ndufs4	B-GP
in	O
the	O
VN	O
.	O

A	O
.	O
Fluorescent	O
images	O
of	O
brain	O
slices	O
from	O
mice	B-OG
injected	O
with	O
active	O
WT	O
-	O
Cre	B-GP
virus	B-OG
into	O
the	O
VN	O
(	O
Coordinates	O
:	O
ML	O
=	O
±	O
1	O
.	O
25	O
;	O
AP	O
=	O
-	O
5	O
.	O
8	O
;	O
DV	O
=	O
4	O
.	O
3	O
,	O
Magnification	O
X40	O
).	O

Virus	B-OG
-	O
infected	O
cells	O
appear	O
green	O
due	O
to	O
the	O
viral	O
GFP	B-GP
co	O
-	O
expression	O
B	O
,	O
C	O
.	O
Schematic	O
figures	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
[	O
24	O
]	O
(	O
Image	O
credit	O
:	O
Allen	O
Institute	O
)	O
depicting	O
the	O
antero	O
-	O
posterior	O
(	O
B	O
),	O
mediolateral	O
(	O
C	O
)	O
and	O
dorso	O
-	O
ventral	O
(	O
C	O
)	O
viral	O
spread	O
(	O
green	O
boxed	O
regions	O
in	O
C	O
).	O

Reprinted	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
under	O
a	O
CC	O
BY	O
license	O
,	O
with	O
permission	O
from	O
the	O
Allen	O
Institute	O
,	O
original	O
copyright	O
2008	O
.	O
D	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
7	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
6	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
LORR	O
assay	O
.	O
E	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
7	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
6	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
TC	O
assay	O
.	O

Scale	O
bar	O
:	O
1mm	O
.	O
**	O
indicates	O
p	O
-	O
values	O
<	O
0	O
.	O
005	O
,	O
***	O
indicates	O
p	O
-	O
values	O
<	O
0	O
.	O
001	O
.	O

The	O
error	O
bars	O
in	O
all	O
bar	O
graphs	O
indicate	O
standard	O
deviation	O
.	O

EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
WT	O
-	O
Cre	B-GP
and	O
Δ	O
-	O
Cre	B-GP
virus	B-OG
-	O
injected	O
mice	B-OG
in	O
the	O
LORR	O
and	O
TC	O
assays	O
.	O

Type	O
of	O
injection	O

Region	O
injected	O

Behavioral	O
test	O

EC50	O
ISO	O
(	O
SD	O
)	O

EC50	O
HAL	O
(	O
SD	O
)	O

N	O
(	O
Gender	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

VN	O

LORR	O

1	O
.	O
00	O
(	O
0	O
.	O
09	O
)	O

0	O
.	O
90	O
(	O
0	O
.	O
05	O
)	O

7	O
(	O
4F	O
/	O
3M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

VN	O

LORR	O

1	O
.	O
1	O
(	O
0	O
.	O
1	O
)	O

1	O
.	O
02	O
(	O
0	O
.	O
08	O
)	O

6	O
(	O
4F	O
/	O
2M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

VN	O

TC	O

1	O
.	O
45	O
(	O
0	O
.	O
09	O
)*	O
p	O
=	O
0	O
.	O
002	O

1	O
.	O
35	O
(	O
0	O
.	O
04	O
)*	O
p	O
=	O
3	O
.	O
6X10	O
-	O
5	O

7	O
(	O
4F	O
/	O
3M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

VN	O

TC	O

1	O
.	O
2	O
(	O
0	O
.	O
1	O
)	O

1	O
.	O
21	O
(	O
0	O
.	O
02	O
)	O

6	O
(	O
4F	O
/	O
2M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

MPTA	O

LORR	O

0	O
.	O
79	O
(	O
0	O
.	O
06	O
)*	O
p	O
=	O
0	O
.	O
01	O

0	O
.	O
82	O
(	O
0	O
.	O
06	O
)	O

6	O
(	O
3F	O
/	O
3M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

MPTA	O

LORR	O

0	O
.	O
90	O
(	O
0	O
.	O
07	O
)	O

0	O
.	O
87	O
(	O
0	O
.	O
04	O
)	O

7	O
(	O
3F	O
/	O
4M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

MPTA	O

TC	O

1	O
.	O
1	O
(	O
0	O
.	O
2	O
)	O

1	O
.	O
1	O
(	O
0	O
.	O
1	O
)	O

6	O
(	O
3F	O
/	O
3M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

MPTA	O

TC	O

1	O
.	O
25	O
(	O
0	O
.	O
05	O
)	O

1	O
.	O
23	O
(	O
0	O
.	O
09	O
)	O

7	O
(	O
3F	O
/	O
4M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

CMT	O

LORR	O

0	O
.	O
80	O
(	O
0	O
.	O
07	O
)*	O
p	O
=	O
0	O
.	O
003	O

0	O
.	O
77	O
(	O
0	O
.	O
07	O
)*	O
p	O
=	O
0	O
.	O
004	O

6	O
(	O
4F	O
/	O
2M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

CMT	O

LORR	O

1	O
.	O
0	O
(	O
0	O
.	O
1	O
)	O

1	O
.	O
0	O
(	O
0	O
.	O
1	O
)	O

6	O
(	O
2F	O
/	O
4M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

CMT	O

TC	O

1	O
.	O
0	O
(	O
0	O
.	O
1	O
)*	O
p	O
=	O
0	O
.	O
008	O

1	O
.	O
02	O
(	O
0	O
.	O
08	O
)*	O
p	O
=	O
3	O
.	O
4X10	O
-	O
5	O

6	O
(	O
4F	O
/	O
2M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

CMT	O

TC	O

1	O
.	O
2	O
(	O
0	O
.	O
1	O
)	O

1	O
.	O
31	O
(	O
0	O
.	O
08	O
)	O

6	O
(	O
2F	O
/	O
4M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

DMT	O

LORR	O

0	O
.	O
80	O
(	O
0	O
.	O
03	O
)*	O
p	O
=	O
0	O
.	O
001	O

0	O
.	O
74	O
(	O
0	O
.	O
02	O
)*	O
p	O
=	O
3	O
.	O
8X10	O
-	O
7	O

6	O
(	O
4F	O
/	O
2M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

DMT	O

LORR	O

0	O
.	O
93	O
(	O
0	O
.	O
04	O
)	O

1	O
.	O
02	O
(	O
0	O
.	O
05	O
)	O

6	O
(	O
2F	O
/	O
4M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

DMT	O

TC	O

0	O
.	O
92	O
(	O
0	O
.	O
09	O
)*	O
p	O
=	O
0	O
.	O
0004	O

0	O
.	O
87	O
(	O
0	O
.	O
04	O
)*	O
p	O
=	O
1	O
.	O
2X10	O
-	O
7	O

6	O
(	O
4F	O
/	O
2M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

DMT	O

TC	O

1	O
.	O
2	O
(	O
0	O
.	O
1	O
)	O

1	O
.	O
33	O
(	O
0	O
.	O
07	O
)	O

6	O
(	O
2F	O
/	O
4M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

PAC	O

LORR	O

0	O
.	O
71	O
(	O
0	O
.	O
05	O
)*	O
p	O
=	O
3	O
.	O
5X10	O
-	O
7	O

0	O
.	O
68	O
(	O
0	O
.	O
06	O
)*	O
p	O
=	O
0	O
.	O
0001	O

6	O
(	O
1F	O
/	O
5M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

PAC	O

LORR	O

0	O
.	O
95	O
(	O
0	O
.	O
02	O
)	O

1	O
.	O
0	O
(	O
0	O
.	O
1	O
)	O

6	O
(	O
3F	O
/	O
3M	O
)	O

AAV	B-OG
-	O
WT	O
-	O
Cre	B-GP
-	O
GFP	B-GP

PAC	O

TC	O

0	O
.	O
85	O
(	O
0	O
.	O
05	O
)*	O
p	O
=	O
9	O
.	O
4X10	O
-	O
8	O

0	O
.	O
77	O
(	O
0	O
.	O
09	O
)*	O
p	O
=	O
5	O
.	O
4X10	O
-	O
7	O

6	O
(	O
1F	O
/	O
5M	O
)	O

AAV	B-OG
-	O
Δ	O
-	O
Cre	B-GP
-	O
GFP	B-GP

PAC	O

TC	O

1	O
.	O
21	O
(	O
0	O
.	O
06	O
)	O

1	O
.	O
23	O
(	O
0	O
.	O
07	O
)	O

6	O
(	O
3F	O
/	O
3M	O
)	O

*	O
indicates	O
p	O
-	O
values	O
<	O
0	O
.	O
01	O
.	O
p	O
values	O
listed	O
compare	O
region	O
specific	O
KO	O
EC50s	O
to	O
control	O
animals	B-OG
injected	O
with	O
sham	O
Cre	B-GP
.	O

Mesopontine	O
tegmental	O
area	O
(	O
MPTA	O
)	O

Based	O
on	O
the	O
data	O
of	O
Devor	O
and	O
colleagues	O
using	O
rats	B-OG
[	O
17	O
],	O
we	O
followed	O
anatomical	O
co	O
-	O
ordinates	O
for	O
mice	B-OG
and	O
injected	O
the	O
WT	O
-	O
Cre	B-GP
(	O
Fig	O
3A	O
,	O
3B	O
and	O
3C	O
)	O
and	O
Δ	O
-	O
Cre	B-GP
viruses	B-OG
(	O
S3B	O
Fig	O
)	O
bilaterally	O
into	O
the	O
calculated	O
mouse	B-OG
brain	O
MPTA	O
.	O

There	O
was	O
no	O
statistically	O
significant	O
change	O
in	O
the	O
TC	O
response	O
of	O
MPTA	O
specific	O
KD	O
to	O
either	O
anesthetic	O
when	O
compared	O
to	O
the	O
sham	O
virus	B-OG
injected	O
group	O
(	O
Fig	O
3E	O
,	O
S4D	O
Fig	O
;	O
Table	O
1	O
).	O

While	O
the	O
KDs	O
did	O
not	O
show	O
any	O
change	O
in	O
sensitivity	O
to	O
HAL	O
for	O
LORR	O
,	O
they	O
showed	O
a	O
statistically	O
significant	O
increase	O
in	O
sensitivity	O
to	O
ISO	O
for	O
LORR	O
(	O
Fig	O
3D	O
,	O
S4C	O
Fig	O
;	O
Table	O
1	O
).	O

Knockdown	O
of	O
Ndufs4	B-GP
in	O
the	O
MPTA	O
.	O

A	O
.	O
Fluorescent	O
images	O
of	O
brain	O
slices	O
from	O
mice	B-OG
injected	O
with	O
active	O
WT	O
-	O
Cre	B-GP
virus	B-OG
(	O
A	O
)	O
into	O
the	O
MPTA	O
(	O
Coordinates	O
:	O
ML	O
=	O
±	O
0	O
.	O
70	O
;	O
AP	O
=	O
-	O
4	O
.	O
6	O
;	O
DV	O
=	O
4	O
.	O
1	O
,	O
Magnification	O
X40	O
).	O
B	O
,	O
C	O
.	O
Schematic	O
figures	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
[	O
24	O
]	O
depicting	O
the	O
viral	O
spread	O
(	O
Image	O
credit	O
:	O
Allen	O
Institute	O
).	O

Reprinted	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
under	O
a	O
CC	O
BY	O
license	O
,	O
with	O
permission	O
from	O
the	O
Allen	O
Institute	O
,	O
original	O
copyright	O
2008	O
.	O
D	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
6	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
7	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
LORR	O
assay	O
.	O
E	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
6	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
7	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
TC	O
assay	O
.	O

Scale	O
bar	O
:	O
1mm	O
.	O
**	O
indicates	O
p	O
-	O
value	O
<	O
0	O
.	O
01	O
.	O

Central	O
medial	O
thalamus	O
(	O
CMT	O
)	O

The	O
CMT	O
is	O
critically	O
involved	O
in	O
sensory	O
relaying	O
to	O
the	O
cortex	O
;	O
this	O
region	O
has	O
been	O
shown	O
to	O
play	O
roles	O
in	O
anesthesia	O
[	O
10	O
,	O
25	O
]	O
and	O
sleep	O
mediation	O
[	O
26	O
].	O

We	O
injected	O
the	O
WT	O
-	O
Cre	B-GP
(	O
Fig	O
4A	O
,	O
4B	O
and	O
4C	O
)	O
and	O
Δ	O
-	O
Cre	B-GP
(	O
S3C	O
Fig	O
)	O
viruses	B-OG
bilaterally	O
into	O
the	O
CMT	O
.	O

Knocking	O
down	O
Ndufs4	B-GP
in	O
the	O
CMT	O
caused	O
hypersensitivity	O
to	O
both	O
ISO	O
and	O
HAL	O
for	O
TC	O
(	O
Fig	O
4E	O
,	O
S4F	O
Fig	O
;	O
Table	O
1	O
).	O

Similarly	O
for	O
LORR	O
,	O
loss	O
of	O
Ndufs4	B-GP
in	O
the	O
CMT	O
made	O
mice	B-OG
hypersensitive	O
to	O
ISO	O
and	O
HAL	O
(	O
Fig	O
4D	O
,	O
S4E	O
Fig	O
;	O
Table	O
1	O
).	O

Knockdown	O
of	O
Ndufs4	B-GP
in	O
the	O
CMT	O
.	O

A	O
.	O
Fluorescent	O
images	O
of	O
brain	O
slices	O
from	O
mice	B-OG
injected	O
with	O
active	O
WT	O
-	O
Cre	B-GP
virus	B-OG
(	O
A	O
)	O
into	O
the	O
CMT	O
(	O
Co	O
-	O
ordinates	O
:	O
ML	O
=	O
±	O
0	O
.	O
32	O
;	O
AP	O
=	O
-	O
1	O
.	O
2	O
;	O
DV	O
=	O
3	O
.	O
85	O
,	O
Magnification	O
X40	O
).	O
B	O
,	O
C	O
.	O
Schematic	O
figures	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
[	O
24	O
]	O
depicting	O
the	O
viral	O
spread	O
(	O
Image	O
credit	O
:	O
Allen	O
Institute	O
).	O

Reprinted	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
under	O
a	O
CC	O
BY	O
license	O
,	O
with	O
permission	O
from	O
the	O
Allen	O
Institute	O
,	O
original	O
copyright	O
2008	O
.	O
D	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
6	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
6	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
LORR	O
assay	O
.	O
E	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
6	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
6	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
TC	O
assay	O
.	O

Scale	O
bar	O
:	O
1mm	O
.	O
**	O
indicates	O
p	O
-	O
values	O
<	O
0	O
.	O
005	O
,	O
***	O
indicates	O
p	O
-	O
values	O
<	O
0	O
.	O
001	O
.	O

Dorsal	O
medial	O
thalamus	O
(	O
DMT	O
)	O

The	O
DMT	O
has	O
been	O
implicated	O
in	O
mediolateral	O
pain	O
modulation	O
and	O
anesthesia	O
mediation	O
by	O
pentobarbital	O
[	O
27	O
].	O

We	O
injected	O
the	O
WT	O
-	O
Cre	B-GP
(	O
Fig	O
5A	O
,	O
5B	O
and	O
5C	O
)	O
and	O
Δ	O
-	O
Cre	B-GP
(	O
S3D	O
Fig	O
)	O
viruses	B-OG
bilaterally	O
into	O
the	O
DMT	O
.	O

Removal	O
of	O
Ndufs4	B-GP
caused	O
significant	O
hypersensitivity	O
to	O
both	O
ISO	O
and	O
HALfor	O
TC	O
(	O
Fig	O
5E	O
,	O
S4H	O
Fig	O
;	O
Table	O
1	O
).	O

Similarly	O
for	O
LORR	O
,	O
loss	O
of	O
Ndufs4	B-GP
in	O
the	O
DMT	O
made	O
mice	B-OG
hypersensitive	O
to	O
ISO	O
and	O
HAL	O
(	O
Fig	O
5D	O
,	O
S4G	O
Fig	O
;	O
Table	O
1	O
).	O

Knockdown	O
of	O
Ndufs4	B-GP
in	O
the	O
DMT	O
.	O

A	O
.	O
Fluorescent	O
images	O
of	O
brain	O
slices	O
from	O
mice	B-OG
injected	O
with	O
active	O
WT	O
-	O
Cre	B-GP
virus	B-OG
(	O
A	O
)	O
into	O
the	O
DMT	O
(	O
Co	O
-	O
ordinates	O
:	O
ML	O
=	O
±	O
0	O
.	O
32	O
;	O
AP	O
=	O
-	O
1	O
.	O
2	O
;	O
DV	O
=	O
3	O
.	O
7	O
,	O
Magnification	O
X40	O
).	O
B	O
,	O
C	O
.	O
Schematic	O
figures	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
[	O
24	O
]	O
depicting	O
the	O
viral	O
spread	O
(	O
Image	O
credit	O
:	O
Allen	O
Institute	O
).	O

Reprinted	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
under	O
a	O
CC	O
BY	O
license	O
,	O
with	O
permission	O
from	O
the	O
Allen	O
Institute	O
,	O
original	O
copyright	O
2008	O
.	O
D	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
6	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
6	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
LORR	O
assay	O
.	O
E	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
6	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
6	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
TC	O
assay	O
.	O

Scale	O
bar	O
:	O
1mm	O
.	O
***	O
indicates	O
p	O
-	O
values	O
<	O
0	O
.	O
001	O
.	O

Parietal	O
association	O
cortex	O
(	O
PAC	O
)	O

The	O
CMT	O
and	O
DMT	O
neurons	O
send	O
major	O
projections	O
into	O
the	O
posterior	O
PAC	O
(	O
Allen	O
Mouse	B-OG
Brain	O
Connectivity	O
Database	O
)	O
[	O
28	O
].	O

The	O
PAC	O
is	O
involved	O
in	O
episodic	O
memory	O
retrieval	O
,	O
spatial	O
reasoning	O
,	O
perception	O
and	O
attention	O
.	O

We	O
surmised	O
that	O
glutamatergic	O
relaying	O
to	O
the	O
cortex	O
might	O
be	O
compromised	O
in	O
the	O
regional	O
knockdown	O
,	O
leading	O
to	O
hypersensitivity	O
to	O
anesthetics	O
.	O

We	O
therefore	O
injected	O
the	O
WT	O
-	O
Cre	B-GP
(	O
Fig	O
6A	O
,	O
6B	O
and	O
6C	O
)	O
and	O
Δ	O
-	O
Cre	B-GP
(	O
S3E	O
Fig	O
)	O
viruses	B-OG
bilaterally	O
into	O
the	O
PAC	O
.	O

Knock	O
down	O
of	O
Ndufs4	B-GP
in	O
the	O
PAC	O
caused	O
the	O
highest	O
level	O
of	O
hypersensitivity	O
recorded	O
in	O
our	O
study	O
for	O
both	O
ISO	O
and	O
HAL	O
for	O
TC	O
(	O
Fig	O
6E	O
,	O
S4J	O
Fig	O
;	O
Table	O
1	O
).	O

For	O
LORR	O
,	O
knockdown	O
of	O
Ndufs4	B-GP
in	O
the	O
PAC	O
caused	O
hypersensitivity	O
to	O
ISO	O
and	O
HAL	O
(	O
EC50	O
(	O
control	O
)	O
1	O
.	O
0	O
±	O
0	O
.	O
1	O
%,	O
EC50	O
(	O
KD	O
)	O
0	O
.	O
68	O
±	O
0	O
.	O
06	O
%;	O
p	O
=	O
0	O
.	O
0001	O
)	O
(	O
Fig	O
6D	O
,	O
S4I	O
Fig	O
;	O
Table	O
1	O
).	O

Knockdown	O
of	O
Ndufs4	B-GP
in	O
the	O
PAC	O
.	O

A	O
.	O
Fluorescent	O
images	O
of	O
brain	O
slices	O
from	O
mice	B-OG
injected	O
with	O
active	O
WT	O
-	O
Cre	B-GP
virus	B-OG
(	O
A	O
)	O
into	O
the	O
PAC	O
(	O
Co	O
-	O
ordinates	O
:	O
ML	O
=	O
±	O
0	O
.	O
80	O
;	O
AP	O
=	O
-	O
1	O
.	O
75	O
;	O
DV	O
=	O
0	O
.	O
9	O
,	O
Magnification	O
X40	O
).	O
B	O
,	O
C	O
.	O
Schematic	O
figures	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
[	O
24	O
]	O
depicting	O
the	O
viral	O
spread	O
(	O
Image	O
credit	O
:	O
Allen	O
Institute	O
).	O

Reprinted	O
from	O
the	O
Allen	O
mouse	B-OG
brain	O
atlas	O
under	O
a	O
CC	O
BY	O
license	O
,	O
with	O
permission	O
from	O
the	O
Allen	O
Institute	O
,	O
original	O
copyright	O
2008	O
.	O
D	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
5	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
6	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
LORR	O
assay	O
.	O
E	O
.	O
EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
active	O
(	O
n	O
=	O
5	O
,	O
black	O
bars	O
)	O
and	O
sham	O
(	O
n	O
=	O
6	O
,	O
grey	O
bars	O
)	O
virus	B-OG
injected	O
mice	B-OG
in	O
the	O
TC	O
assay	O
.	O

Scale	O
bar	O
:	O
1mm	O
.	O
***	O
indicates	O
p	O
-	O
values	O
<	O
0	O
.	O
001	O
.	O

Brightly	O
fluorescing	O
cells	O
also	O
appeared	O
in	O
the	O
central	O
thalamus	O
of	O
the	O
brains	O
of	O
mice	B-OG
injected	O
with	O
the	O
Δ	O
–	O
Cre	B-GP
and	O
WT	O
-	O
Cre	B-GP
viruses	B-OG
(	O
Fig	O
7	O
)	O
into	O
the	O
PAC	O
.	O

This	O
provides	O
evidence	O
of	O
anterograde	O
transmission	O
of	O
the	O
GFP	B-GP
signal	O
from	O
the	O
PAC	O
to	O
the	O
thalamus	O
and	O
for	O
the	O
existence	O
of	O
a	O
thalamocortical	O
circuit	O
possibly	O
involved	O
in	O
mediating	O
the	O
anesthetic	O
sensitivity	O
of	O
the	O
Ndufs4	B-GP
(	O
KO	O
)	O
mice	B-OG
[	O
3	O
].	O

To	O
determine	O
whether	O
the	O
excitatory	O
neurotransmission	O
in	O
the	O
PAC	O
circuit	O
is	O
compromised	O
by	O
Ndufs4	B-GP
mutation	O
,	O
we	O
recorded	O
the	O
field	O
excitatory	O
postsynaptic	O
potentials	O
(	O
fEPSPs	O
)	O
in	O
the	O
PAC	O
of	O
sagittal	O
brain	O
slices	O
of	O
Ndufs4	B-GP
(	O
KO	O
)	O
and	O
control	O
sibling	O
mice	B-OG
(	O
Fig	O
8	O
).	O

The	O
amplitudes	O
of	O
fEPSPs	O
in	O
the	O
PAC	O
were	O
significantly	O
decreased	O
during	O
0	O
.	O
6	O
%	O
ISO	O
exposure	O
(	O
corresponds	O
to	O
248	O
μM	O
at	O
room	O
temperature	O
)	O
in	O
the	O
Ndufs4	B-GP
(	O
KO	O
)	O
when	O
compared	O
to	O
the	O
control	O
slices	O
(	O
p	O
=	O
0	O
.	O
00008	O
).	O

There	O
was	O
a	O
trend	O
for	O
decrease	O
in	O
the	O
fiber	O
volley	O
amplitude	O
of	O
the	O
global	O
KO	O
brain	O
slices	O
during	O
0	O
.	O
6	O
%	O
ISO	O
exposure	O
when	O
compared	O
to	O
the	O
control	O
brain	O
slices	O
,	O
however	O
the	O
change	O
did	O
not	O
reach	O
statistical	O
significance	O
(	O
p	O
=	O
0	O
.	O
015	O
).	O

The	O
thalamocortical	O
circuit	O
.	O

A	O
.	O
Fluorescent	O
image	O
of	O
a	O
brain	O
slice	O
from	O
a	O
mouse	B-OG
injected	O
with	O
Δ	O
-	O
Cre	B-GP
virus	B-OG
into	O
the	O
PAC	O
(	O
Magnification	O
X40	O
).	O
B	O
.	O
Magnified	O
confocal	O
image	O
of	O
the	O
white	O
-	O
boxed	O
region	O
within	O
the	O
thalamus	O
in	O
A	O
(	O
Magnification	O
X200	O
).	O

C	O
.	O
Magnified	O
confocal	O
image	O
of	O
white	O
boxed	O
region	O
in	O
B	O
showing	O
viral	O
-	O
GFP	B-GP
expressing	O
cells	O
in	O
the	O
thalamus	O
following	O
injection	O
into	O
the	O
PAC	O
(	O
Magnification	O
X1000	O
).	O

Scale	O
bars	O
:	O
A	O
-	O
1mm	O
,	O
B	O
-	O
50μm	O
,	O
C	O
-	O
10μm	O
.	O

Electrophysiological	O
field	O
recordings	O
of	O
the	O
excitatory	O
synaptic	O
transmission	O
.	O

A	O
.	O
Amplitudes	O
of	O
fEPSPs	O
decreased	O
with	O
0	O
.	O
6	O
%	O
(	O
248	O
μM	O
)	O
ISO	O
exposure	O
in	O
control	O
and	O
Ndufs4	B-GP
(	O
KO	O
)	O
brain	O
slices	O
.	O

The	O
decrease	O
of	O
fEPSPs	O
was	O
significantly	O
greater	O
for	O
the	O
Ndufs4	B-GP
(	O
KO	O
)	O
than	O
the	O
control	O
(***	O
indicates	O
p	O
-	O
value	O
<	O
0	O
.	O
001	O
).	O
B	O
.	O
Fiber	O
volleys	O
of	O
both	O
genotypes	O
were	O
not	O
significantly	O
affected	O
by	O
the	O
isoflurane	O
exposure	O
.	O
C	O
.	O
Representative	O
traces	O
of	O
field	O
recordings	O
from	O
control	O
and	O
KO	O
slices	O
before	O
and	O
during	O
exposure	O
to	O
0	O
.	O
6	O
%	O
ISO	O
(	O
equivalent	O
to	O
248	O
μM	O
).	O

0	O
.	O
6	O
%	O
ISO	O
exposure	O
led	O
to	O
a	O
significantly	O
larger	O
decrease	O
in	O
the	O
amplitudes	O
of	O
fEPSP	O
in	O
the	O
KO	O
when	O
compared	O
to	O
the	O
respective	O
decrease	O
in	O
controls	O
.	O

The	O
amplitudes	O
of	O
the	O
fiber	O
volleys	O
were	O
decreased	O
(	O
statistically	O
tending	O
to	O
significance	O
,	O
p	O
=	O
0	O
.	O
015	O
)	O
by	O
0	O
.	O
6	O
%	O
ISO	O
exposure	O
in	O
both	O
genotypes	O
.	O

Discussion	O

Inactivation	O
of	O
a	O
complex	B-GP
I	I-GP
subunit	O
in	O
the	O
thalamocortical	O
circuit	O
caused	O
striking	O
VA	O
hypersensitivity	O
to	O
both	O
the	O
LORR	O
and	O
TC	O
responses	O
.	O

The	O
degrees	O
of	O
change	O
are	O
especially	O
noteworthy	O
given	O
that	O
inactivation	O
specifically	O
knocked	O
down	O
levels	O
of	O
the	O
protein	O
only	O
in	O
very	O
confined	O
regions	O
of	O
the	O
CNS	O
,	O
after	O
development	O
was	O
largely	O
completed	O
.	O

Acute	O
local	O
inactivation	O
of	O
a	O
mitochondrial	O
gene	O
in	O
an	O
otherwise	O
wild	O
type	O
mouse	B-OG
minimizes	O
compensatory	O
developmental	O
changes	O
or	O
latent	O
nonspecific	O
CNS	O
degeneration	O
seen	O
in	O
the	O
global	O
KO	O
,	O
as	O
potential	O
confounders	O
of	O
data	O
interpretation	O
.	O

Although	O
we	O
did	O
not	O
measure	O
mitochondrial	O
function	O
in	O
these	O
microscopic	O
regions	O
of	O
the	O
brain	O
,	O
we	O
infer	O
that	O
complex	B-GP
I	I-GP
function	O
is	O
defective	O
in	O
the	O
regions	O
where	O
Ndufs4	B-GP
is	O
knocked	O
down	O
.	O

In	O
turn	O
,	O
we	O
interpret	O
these	O
data	O
to	O
indicate	O
that	O
anesthetic	O
hypersensitivity	O
here	O
results	O
specifically	O
from	O
acute	O
mitochondrial	O
dysfunction	O
.	O

The	O
simplest	O
explanation	O
of	O
our	O
data	O
is	O
that	O
VAs	O
directly	O
inhibit	O
complex	B-GP
I	I-GP
function	O
[	O
29	O
];	O
the	O
resulting	O
region	O
-	O
specific	O
decrease	O
in	O
metabolism	O
leads	O
to	O
the	O
anesthetized	O
state	O
.	O

Regional	O
metabolism	O
is	O
certainly	O
altered	O
in	O
the	O
CNS	O
while	O
anesthetized	O
,	O
but	O
this	O
may	O
result	O
from	O
or	O
cause	O
the	O
anesthetized	O
state	O
[	O
19	O
,	O
25	O
,	O
30	O
].	O

However	O
,	O
we	O
know	O
that	O
defects	O
in	O
mitochondrial	B-GP
complex	I-GP
I	I-GP
increase	O
anesthetic	O
sensitivity	O
without	O
known	O
changes	O
in	O
ion	O
channel	O
characteristics	O
[	O
9	O
].	O

In	O
addition	O
,	O
the	O
EC50	O
of	O
the	O
Ndufs4	B-GP
(	O
KO	O
)	O
mutant	O
,	O
0	O
.	O
4	O
%	O
isoflurane	O
,	O
is	O
well	O
below	O
the	O
concentration	O
that	O
produces	O
significant	O
effects	O
in	O
putative	O
VA	O
targets	O
that	O
may	O
reduce	O
regional	O
metabolism	O
as	O
a	O
secondary	O
effect	O
.	O

Given	O
that	O
complex	B-GP
I	I-GP
dysfunction	O
profoundly	O
sensitizes	O
worms	B-OG
,	O
mice	B-OG
and	O
children	O
to	O
VAs	O
[	O
1	O
–	O
3	O
,	O
31	O
],	O
this	O
effect	O
appears	O
highly	O
conserved	O
across	O
the	O
animal	B-OG
kingdom	O
.	O

Mitochondrial	O
function	O
represents	O
a	O
key	O
component	O
of	O
normal	O
CNS	O
metabolism	O
,	O
since	O
oxidative	O
phosphorylation	O
is	O
necessary	O
for	O
synaptic	O
function	O
[	O
32	O
,	O
33	O
].	O

Complex	B-GP
I	I-GP
is	O
the	O
rate	O
limiting	O
step	O
of	O
electron	O
transport	O
[	O
34	O
,	O
35	O
];	O
isolated	O
mitochondria	O
from	O
the	O
Ndufs4	B-GP
(	O
KO	O
)	O
brain	O
display	O
significantly	O
reduced	O
Complex	B-GP
I	I-GP
activity	O
[	O
7	O
].	O

Prior	O
hypotheses	O
suggested	O
a	O
generalized	O
decrease	O
in	O
neuronal	O
activity	O
as	O
a	O
mechanism	O
of	O
anesthesia	O
[	O
10	O
,	O
12	O
].	O

However	O
,	O
recent	O
work	O
indicates	O
that	O
localized	O
CNS	O
effects	O
may	O
underlie	O
the	O
anesthetic	O
state	O
and	O
multiple	O
regions	O
have	O
been	O
suggested	O
as	O
mediating	O
these	O
effects	O
[	O
14	O
,	O
19	O
,	O
30	O
,	O
36	O
,	O
37	O
].	O

The	O
data	O
presented	O
here	O
highlight	O
the	O
probable	O
importance	O
of	O
normal	O
mitochondrial	O
function	O
within	O
very	O
circumscribed	O
key	O
regions	O
of	O
the	O
brain	O
that	O
are	O
necessary	O
to	O
support	O
normal	O
response	O
to	O
anesthetics	O
.	O

The	O
anesthetic	O
inhibition	O
of	O
response	O
to	O
TC	O
is	O
thought	O
to	O
result	O
from	O
effects	O
on	O
the	O
spinal	O
cord	O
with	O
some	O
supraspinal	O
modification	O
[	O
18	O
,	O
38	O
].	O

The	O
LORR	O
is	O
used	O
as	O
a	O
surrogate	O
for	O
unconsciousness	O
[	O
39	O
,	O
40	O
].	O

Our	O
results	O
demonstrate	O
different	O
phenotypes	O
for	O
these	O
endpoints	O
mediated	O
by	O
mitochondrial	O
dysfunction	O
in	O
various	O
regions	O
of	O
the	O
brain	O
.	O

We	O
discuss	O
LORR	O
and	O
TC	O
separately	O
below	O
.	O

Loss	O
of	O
righting	O
reflex	O

It	O
is	O
known	O
that	O
the	O
thalamus	O
displays	O
suppressed	O
metabolism	O
[	O
19	O
]	O
and	O
decreased	O
synaptic	O
activity	O
during	O
anesthesia	O
[	O
37	O
,	O
41	O
].	O

The	O
hypersensitivity	O
seen	O
in	O
our	O
animals	B-OG
after	O
viral	O
injection	O
into	O
the	O
medial	O
thalamus	O
corroborates	O
a	O
role	O
for	O
the	O
medial	O
thalamic	O
nuclei	O
in	O
determining	O
anesthetic	O
sensitivity	O
for	O
LORR	O
.	O

Our	O
results	O
support	O
electrophysiologic	O
work	O
showing	O
thalamocortical	O
activity	O
correlated	O
with	O
anesthetic	O
depth	O
[	O
42	O
].	O

Since	O
the	O
medial	O
thalamus	O
relays	O
glutamatergic	O
signals	O
to	O
the	O
cortex	O
[	O
43	O
,	O
44	O
],	O
VAs	O
likely	O
exert	O
their	O
effects	O
through	O
suppression	O
of	O
these	O
pathways	O
.	O

The	O
mouse	B-OG
connectivity	O
database	O
of	O
the	O
Allen	O
Institute	O
also	O
shows	O
projections	O
from	O
the	O
central	O
medial	O
thalamus	O
populating	O
the	O
parietal	O
association	O
cortex	O
[	O
28	O
,	O
45	O
].	O

We	O
have	O
confirmed	O
a	O
circuit	O
between	O
the	O
PAC	O
and	O
the	O
thalamus	O
,	O
with	O
reciprocal	O
projections	O
from	O
the	O
PAC	O
to	O
the	O
thalamus	O
.	O

Viral	O
inactivation	O
of	O
Ndufs4	B-GP
in	O
the	O
PAC	O
reveals	O
that	O
this	O
region	O
contributes	O
about	O
1	O
/	O
2	O
of	O
the	O
hypersensitivity	O
displayed	O
by	O
the	O
whole	O
body	O
Ndufs4	B-GP
(	O
KO	O
)	O
for	O
ISO	O
and	O
HAL	O
in	O
the	O
LORR	O
assay	O
(	O
Table	O
1	O
).	O

The	O
reduced	O
fEPSP	O
amplitudes	O
in	O
the	O
PAC	O
of	O
Ndufs4	B-GP
global	O
KO	O
during	O
0	O
.	O
6	O
%	O
ISO	O
exposure	O
likely	O
contributes	O
to	O
the	O
increased	O
VA	O
sensitivity	O
seen	O
in	O
the	O
global	O
KO	O
.	O

This	O
is	O
consistent	O
with	O
studies	O
demonstrating	O
that	O
dexmedetomidine	O
induced	O
loss	O
of	O
consciousness	O
in	O
healthy	O
volunteers	O
preferentially	O
decreased	O
cerebral	O
glucose	O
metabolic	O
rate	O
and	O
blood	O
flow	O
in	O
thalamus	O
and	O
in	O
an	O
area	O
corresponding	O
to	O
the	O
PAC	O
of	O
mice	B-OG
[	O
19	O
].	O

While	O
the	O
functional	O
connectivity	O
within	O
cortical	O
regions	O
was	O
preserved	O
,	O
connectivity	O
between	O
medial	O
thalamus	O
and	O
the	O
cortical	O
regions	O
was	O
disrupted	O
during	O
the	O
unconscious	O
state	O
and	O
re	O
-	O
established	O
during	O
regain	O
of	O
consciousness	O
.	O

This	O
same	O
area	O
,	O
part	O
of	O
a	O
larger	O
region	O
called	O
the	O
DMN	O
(	O
default	O
mode	O
network	O
)	O
in	O
humans	B-OG
[	O
46	O
],	O
shows	O
a	O
direct	O
correlation	O
between	O
connectivity	O
within	O
the	O
DMN	O
and	O
levels	O
of	O
consciousness	O
in	O
patients	O
with	O
disorders	O
of	O
consciousness	O
[	O
47	O
,	O
48	O
].	O

We	O
conclude	O
that	O
the	O
thalamocortical	O
sensory	O
relaying	O
is	O
bioenergetically	O
demanding	O
and	O
sensitive	O
to	O
mitochondrial	O
inhibition	O
by	O
VAs	O
.	O

Studies	O
by	O
Devor	O
and	O
colleagues	O
in	O
rats	B-OG
have	O
shown	O
that	O
the	O
mesopontine	O
tegmental	O
anesthetic	O
area	O
(	O
MPTA	O
)	O
is	O
important	O
for	O
mediating	O
anesthetic	O
LORR	O
sensitivity	O
to	O
pentobarbital	O
[	O
17	O
].	O

However	O
,	O
we	O
found	O
MPTA	O
KD	O
mice	B-OG
were	O
mildly	O
hypersensitive	O
only	O
to	O
ISO	O
for	O
LORR	O
.	O

It	O
is	O
possible	O
that	O
our	O
injections	O
did	O
not	O
localize	O
to	O
the	O
MPTA	O
,	O
or	O
the	O
precise	O
location	O
of	O
the	O
MPTA	O
may	O
differ	O
between	O
the	O
rat	B-OG
and	O
mouse	B-OG
brain	O
.	O

It	O
is	O
also	O
possible	O
that	O
the	O
MPTA	O
is	O
not	O
an	O
important	O
region	O
for	O
mediating	O
the	O
anesthetic	O
sensitivity	O
of	O
HAL	O
,	O
or	O
that	O
the	O
mitochondrial	O
mutation	O
mediates	O
anesthetic	O
hypersensitivity	O
by	O
exerting	O
regional	O
effects	O
elsewhere	O
.	O

Tail	O
clamp	O

Similar	O
to	O
the	O
effects	O
on	O
LORR	O
,	O
Ndufs4	B-GP
loss	O
in	O
the	O
CMT	O
/	O
DMT	O
and	O
PAC	O
accounts	O
for	O
approximately	O
half	O
of	O
the	O
hypersensitivity	O
displayed	O
by	O
the	O
whole	O
body	O
KO	O
for	O
ISO	O
and	O
HAL	O
in	O
the	O
TC	O
assay	O
[	O
3	O
].	O

The	O
ascending	O
spinal	O
cord	O
and	O
the	O
ventro	O
-	O
posterior	O
brain	O
stem	O
nuclei	O
of	O
the	O
primary	O
somatic	O
pathways	O
transmit	O
nociceptive	O
signals	O
from	O
the	O
peripheral	O
nervous	O
system	O
to	O
the	O
somatosensory	O
,	O
the	O
parieto	O
-	O
insular	O
and	O
the	O
anterior	O
cingulate	O
cortices	O
resulting	O
in	O
pain	O
perception	O
[	O
49	O
,	O
50	O
].	O

The	O
medial	O
thalamus	O
is	O
involved	O
in	O
the	O
medial	O
pain	O
perception	O
pathway	O
and	O
is	O
suppressed	O
by	O
pentobarbital	O
during	O
noxious	O
stimulation	O
[	O
27	O
].	O

The	O
DMT	O
also	O
drives	O
feed	O
forward	O
inhibition	O
of	O
the	O
anterior	O
cingulate	O
cortex	O
to	O
limit	O
excitatory	O
input	O
processing	O
and	O
firing	O
of	O
cortical	O
neurons	O
,	O
resulting	O
in	O
better	O
temporal	O
precision	O
of	O
the	O
circuit	O
[	O
51	O
].	O

Similar	O
to	O
the	O
effects	O
on	O
LORR	O
,	O
we	O
propose	O
that	O
mitochondrial	O
dysfunction	O
disrupts	O
the	O
temporal	O
fidelity	O
within	O
the	O
thalamocortical	O
circuits	O
such	O
that	O
the	O
pain	O
perception	O
pathway	O
is	O
inhibited	O
more	O
completely	O
by	O
ISO	O
and	O
HAL	O
when	O
mitochondrial	O
dysfunction	O
is	O
present	O
prior	O
to	O
anesthetic	O
exposure	O
.	O

It	O
is	O
interesting	O
that	O
VN	O
-	O
specific	O
Ndufs4	B-GP
KD	O
caused	O
resistance	O
to	O
VAs	O
in	O
the	O
tail	O
clamp	O
assay	O
.	O

In	O
contrast	O
to	O
the	O
role	O
played	O
by	O
the	O
cortex	O
in	O
central	O
pain	O
perception	O
,	O
the	O
higher	O
brain	O
centers	O
have	O
also	O
been	O
shown	O
to	O
modulate	O
nociceptive	O
transmission	O
so	O
that	O
spinal	O
transection	O
increases	O
nociceptive	O
reflexes	O
[	O
52	O
].	O

The	O
descending	O
spinal	O
cord	O
modulatory	O
effects	O
by	O
the	O
higher	O
brain	O
centers	O
could	O
be	O
facilitating	O
or	O
inhibitory	O
[	O
53	O
,	O
54	O
].	O

Antognini	O
et	O
al	O
.	O
showed	O
that	O
preferential	O
anesthetization	O
of	O
the	O
goat	B-OG
brain	O
bypassing	O
the	O
spinal	O
cord	O
increased	O
the	O
isoflurane	O
requirement	O
to	O
inhibit	O
the	O
sensitivity	O
to	O
dew	O
-	O
claw	O
stimulation	O
[	O
18	O
].	O

Rampil	O
et	O
al	O
.	O
showed	O
that	O
depression	O
of	O
the	O
spinal	O
motor	O
neurons	O
may	O
contribute	O
to	O
the	O
lack	O
of	O
response	O
to	O
painful	O
stimuli	O
mediated	O
by	O
various	O
inhalational	O
anesthetics	O
in	O
rats	B-OG
[	O
55	O
,	O
56	O
].	O

Our	O
results	O
are	O
most	O
consistent	O
with	O
descending	O
inhibitory	O
signaling	O
through	O
the	O
VN	O
to	O
the	O
spinal	O
cord	O
being	O
decreased	O
by	O
the	O
Ndufs4	B-GP
(	O
KO	O
).	O

We	O
propose	O
that	O
the	O
excitatory	O
thalamocortical	O
firing	O
to	O
the	O
PAC	O
mediates	O
both	O
consciousness	O
and	O
nociception	O
.	O

The	O
posterior	O
brain	O
stem	O
acts	O
as	O
a	O
switch	O
between	O
nociception	O
,	O
during	O
which	O
excitatory	O
cortical	O
firing	O
to	O
the	O
brain	O
stem	O
dominates	O
,	O
and	O
antinociception	O
,	O
during	O
which	O
inhibitory	O
cortical	O
firing	O
to	O
the	O
VN	O
and	O
the	O
downstream	O
spinal	O
neurons	O
dominates	O
.	O

Supporting	O
the	O
model	O
,	O
glucose	O
uptake	O
[	O
57	O
]	O
and	O
c	B-GP
-	I-GP
FOS	I-GP
staining	O
[	O
58	O
]	O
in	O
the	O
VN	O
increased	O
during	O
isoflurane	O
anesthesia	O
,	O
indicating	O
that	O
the	O
anesthetized	O
state	O
may	O
require	O
increased	O
energy	O
production	O
in	O
the	O
VN	O
which	O
is	O
rendered	O
inadequate	O
by	O
the	O
mitochondrial	O
mutation	O
.	O

Conclusion	O

We	O
report	O
the	O
first	O
demonstration	O
linking	O
regional	O
CNS	O
inactivation	O
of	O
a	O
mitochondrial	O
protein	O
to	O
sensitivity	O
to	O
volatile	O
anesthetics	O
.	O

We	O
infer	O
that	O
localized	O
knockdown	O
of	O
NDUFS4	B-GP
results	O
in	O
a	O
regional	O
defect	O
in	O
mitochondrial	O
respiration	O
as	O
is	O
seen	O
in	O
the	O
global	O
KO	O
.	O

Mitochondria	O
therefore	O
represent	O
a	O
putative	O
novel	O
target	O
for	O
volatile	O
anesthetics	O
.	O

Restriction	O
of	O
mitochondrial	O
defects	O
to	O
the	O
thalamocortical	O
circuit	O
causes	O
greater	O
than	O
half	O
of	O
the	O
change	O
in	O
anesthetic	O
sensitivities	O
seen	O
in	O
the	O
total	O
loss	O
of	O
the	O
Ndufs4	B-GP
gene	O
.	O

Regional	O
bioenergetic	O
capacities	O
and	O
mitochondrial	O
function	O
are	O
likely	O
an	O
important	O
determinant	O
of	O
response	O
to	O
volatile	O
anesthetics	O
,	O
and	O
may	O
underlie	O
the	O
mechanism	O
of	O
action	O
of	O
volatile	O
anesthetics	O
.	O

Materials	O
and	O
methods	O

Animal	B-OG
maintenance	O

All	O
studies	O
were	O
approved	O
by	O
the	O
Animal	B-OG
Care	O
and	O
Use	O
Committee	O
of	O
the	O
Seattle	O
Children	O
’	O
s	O
Research	O
Institute	O
.	O

Mice	B-OG
were	O
maintained	O
on	O
standard	O
rodent	O
diet	O
at	O
22	O
°	O
C	O
with	O
12	O
-	O
hour	O
dark	O
/	O
light	O
cycles	O
.	O
Ndufs4lox	O
/	O
lox	O
mice	B-OG
with	O
a	O
mixed	O
129	O
/	O
Sv	O
:	O
C57Bl	O
/	O
6	O
genetic	O
background	O
[	O
6	O
]	O
were	O
a	O
kind	O
gift	O
from	O
Richard	O
Palmiter	O
(	O
Howard	O
Hughes	O
Medical	O
Institute	O
and	O
the	O
University	O
of	O
Washington	O
,	O
Seattle	O
,	O
WA	O
).	O

Intracranial	O
virus	B-OG
delivery	O

The	O
adeno	B-OG
-	I-OG
associated	I-OG
viruses	I-OG
rAAV	O
/	O
WT	O
-	O
Cre	B-GP
GFP	B-GP
and	O
the	O
rAAV	O
/	O
Delta	O
(	O
Δ	O
)-	O
Cre	B-GP
GFP	B-GP
viruses	B-OG
[	O
59	O
,	O
60	O
]	O
were	O
purchased	O
from	O
UNC	O
Vector	O
Core	O
(	O
Chapel	O
Hill	O
,	O
NC	O
)	O
and	O
diluted	O
in	O
PBS	O
at	O
a	O
titer	O
of	O
2	O
×	O
109	O
viral	O
genomes	O
/	O
μl	O
.	O

These	O
viruses	B-OG
encode	O
wild	O
-	O
type	O
active	O
Cre	B-GP
-	I-GP
recombinase	I-GP
(	O
WT	O
-	O
Cre	B-GP
,	O
active	O
)	O
or	O
mutated	O
defective	O
Cre	B-GP
-	I-GP
recombinase	I-GP
(	O
Δ	O
-	O
Cre	B-GP
,	O
control	O
)	O
respectively	O
and	O
green	B-GP
fluorescent	I-GP
protein	I-GP
(	O
GFP	B-GP
)	O
and	O
are	O
known	O
to	O
be	O
taken	O
up	O
by	O
all	O
types	O
of	O
cells	O
in	O
the	O
injected	O
region	O
[	O
61	O
].	O

Delivery	O
of	O
active	O
Cre	B-GP
expressing	O
AAV	B-OG
to	O
the	O
various	O
regions	O
of	O
Ndufs4lox	O
/	O
lox	O
mice	B-OG
brains	O
created	O
region	O
-	O
specific	O
loss	O
of	O
the	O
protein	O
NDUFS4	B-GP
.	O

Male	O
and	O
female	O
animals	B-OG
aged	O
between	O
35	O
to	O
40	O
days	O
of	O
age	O
were	O
anesthetized	O
with	O
isoflurane	O
and	O
either	O
virus	B-OG
was	O
injected	O
into	O
various	O
brain	O
regions	O
using	O
the	O
motorized	O
Robot	O
stereotax	O
(	O
Neurostar	O
GmbH	O
,	O
Tubingen	O
,	O
Germany	O
)	O
as	O
per	O
manufacturer	O
instructions	O
.	O

Briefly	O
,	O
the	O
anesthetized	O
mouse	B-OG
was	O
attached	O
to	O
the	O
stereotax	O
with	O
inline	O
isoflurane	O
(	O
induction	O
with	O
5	O
%	O
ISO	O
and	O
maintenance	O
with	O
1	O
.	O
5	O
%	O
ISO	O
)	O
delivered	O
through	O
a	O
face	O
mask	O
.	O

An	O
incision	O
was	O
made	O
on	O
the	O
shaved	O
and	O
sterilized	O
supracranial	O
skin	O
exposing	O
the	O
skull	O
.	O

Either	O
virus	B-OG
was	O
injected	O
using	O
a	O
motorized	O
injector	O
after	O
drilling	O
holes	O
in	O
the	O
cranium	O
at	O
stereotaxically	O
defined	O
bilateral	O
locations	O
.	O

The	O
quantities	O
and	O
co	O
-	O
ordinates	O
of	O
the	O
viral	O
injections	O
are	O
listed	O
in	O
S2	O
Table	O
.	O

For	O
VN	O
,	O
CMT	O
,	O
DMT	O
and	O
PAC	O
,	O
coordinates	O
were	O
used	O
from	O
the	O
Allen	O
Brain	O
Atlas	O
.	O

The	O
location	O
of	O
the	O
MPTA	O
was	O
approximated	O
by	O
using	O
rat	B-OG
coordinates	O
.	O

The	O
mice	B-OG
were	O
allowed	O
to	O
recover	O
for	O
3	O
weeks	O
before	O
behavioral	O
testing	O
using	O
halothane	O
(	O
HAL	O
)	O
or	O
isoflurane	O
(	O
ISO	O
).	O

Behavioral	O
testing	O

Mice	B-OG
were	O
anesthetized	O
with	O
ISO	O
or	O
HAL	O
and	O
assayed	O
for	O
LORR	O
or	O
response	O
to	O
TC	O
as	O
described	O
by	O
Sonner	O
et	O
al	O
.	O
[	O
62	O
]	O
and	O
the	O
anesthetic	O
concentrations	O
analyzed	O
by	O
gas	O
chromatography	O
[	O
63	O
].	O

The	O
EC50s	O
for	O
loss	O
of	O
response	O
to	O
TC	O
were	O
used	O
as	O
the	O
equivalent	O
of	O
minimum	O
anesthetic	O
concentrations	O
(	O
MAC	O
)	O
for	O
loss	O
of	O
nociceptive	O
motor	O
response	O
.	O

The	O
EC50s	O
for	O
the	O
loss	O
of	O
righting	O
reflex	O
were	O
used	O
as	O
a	O
measure	O
of	O
the	O
consciousness	O
status	O
of	O
the	O
animal	B-OG
.	O

Animals	B-OG
were	O
kept	O
warm	O
on	O
a	O
heating	O
pad	O
throughout	O
and	O
allowed	O
to	O
recover	O
for	O
at	O
least	O
24	O
h	O
between	O
behavioral	O
assays	O
.	O

Each	O
animal	B-OG
underwent	O
TC	O
and	O
LORR	O
testing	O
in	O
a	O
randomized	O
order	O
.	O

No	O
significant	O
differences	O
were	O
noted	O
between	O
the	O
anesthetic	O
sensitivity	O
of	O
the	O
subjected	O
mice	B-OG
due	O
to	O
prior	O
anesthetic	O
exposure	O
during	O
the	O
randomized	O
tests	O
.	O

The	O
EC50	O
for	O
an	O
anesthetic	O
was	O
the	O
average	O
of	O
the	O
concentrations	O
for	O
induction	O
(	O
defined	O
as	O
the	O
average	O
concentrations	O
of	O
gas	O
in	O
the	O
last	O
sample	O
before	O
loss	O
of	O
response	O
and	O
in	O
the	O
first	O
sample	O
at	O
which	O
the	O
response	O
was	O
lost	O
)	O
and	O
emergence	O
(	O
defined	O
as	O
the	O
average	O
concentration	O
of	O
gas	O
in	O
the	O
first	O
sample	O
at	O
which	O
the	O
animal	B-OG
once	O
again	O
responded	O
,	O
and	O
the	O
sample	O
immediately	O
prior	O
).	O

Mice	B-OG
were	O
tested	O
at	O
3	O
weeks	O
after	O
virus	B-OG
injection	O
for	O
both	O
behavioral	O
endpoints	O
in	O
both	O
anesthetics	O
.	O

All	O
animals	B-OG
survived	O
the	O
anesthetic	O
exposures	O
.	O

They	O
were	O
then	O
sacrificed	O
for	O
immunohistochemical	O
analyses	O
at	O
28	O
days	O
after	O
injection	O
.	O

Histopathological	O
analyses	O

Mice	B-OG
were	O
euthanized	O
using	O
CO2	O
,	O
and	O
brains	O
were	O
fixed	O
in	O
cold	O
4	O
%	O
paraformaldehyde	O
,	O
postfixed	O
overnight	O
at	O
4	O
°	O
C	O
,	O
cryoprotected	O
in	O
30	O
%	O
sucrose	O
-	O
PBS	O
for	O
three	O
days	O
and	O
embedded	O
in	O
optimal	O
cutting	O
temperature	O
compound	O
(	O
OCT	O
).	O

Brains	O
were	O
then	O
sliced	O
at	O
30	O
μm	O
thickness	O
and	O
serial	O
slices	O
were	O
collected	O
in	O
PBS	O
in	O
24	O
-	O
well	O
dishes	O
.	O

Slices	O
at	O
180μm	O
intervals	O
were	O
selected	O
and	O
mounted	O
on	O
glass	O
slides	O
,	O
analyzed	O
and	O
imaged	O
under	O
a	O
fluorescence	O
microscope	O
(	O
upright	O
Zeiss	O
Axioskop	O
equipped	O
with	O
an	O
Attoarc	O
100W	O
HBO	O
lamp	O
,	O
an	O
Axiocam	O
color	O
charge	O
-	O
coupled	O
device	O
camera	O
(	O
type	O
412	O
–	O
312	O
)	O
and	O
Axiovision	O
v3	O
.	O
1	O
software	O
)	O
to	O
assess	O
the	O
viral	O
spread	O
of	O
infection	B-DS
.	O

For	O
heat	O
-	O
induced	O
epitope	O
retrieval	O
,	O
captured	O
slices	O
on	O
glass	O
slides	O
were	O
boiled	O
in	O
10mM	O
sodium	O
citrate	O
buffer	O
(	O
pH	O
6	O
.	O
0	O
)	O
at	O
100	O
°	O
C	O
for	O
20	O
minutes	O
using	O
a	O
water	O
bath	O
[	O
64	O
].	O

Slides	O
were	O
then	O
blocked	O
in	O
PBS	O
with	O
10	O
%	O
normal	O
donkey	B-OG
serum	O
overnight	O
at	O
4	O
°	O
C	O
.	O

Primary	O
antibodies	B-GP
,	O
mouse	B-OG
anti	O
-	O
NDUFS4	B-GP
(	O
Santa	O
Cruz	O
;	O
dilution	O
1	O
:	O
50	O
),	O
mouse	B-OG
anti	O
-	O
cytochrome	B-GP
C	I-GP
(	O
MitoSciences	O
;	O
dilution	O
1	O
:	O
300	O
)	O
and	O
goat	B-OG
anti	O
-	O
GFP	B-GP
(	O
Abcam	O
;	O
dilution	O
1	O
:	O
200	O
)	O
were	O
incubated	O
overnight	O
at	O
4	O
°	O
C	O
.	O

Secondary	O
antibodies	B-GP
,	O
rabbit	B-OG
anti	O
-	O
mouse	B-OG
Alexa	O
Fluor	O
568	O
(	O
Life	O
Technologies	O
;	O
dilution	O
1	O
:	O
2000	O
)	O
and	O
donkey	B-OG
anti	O
-	O
goat	B-OG
AlexaFluor	O
488	O
(	O
Life	O
Technologies	O
;	O
dilution	O
1	O
:	O
2000	O
)	O
were	O
incubated	O
for	O
one	O
hour	O
at	O
RT	O
.	O

After	O
mounting	O
the	O
slices	O
in	O
DAPI	O
Fluoromount	O
-	O
G	O
solution	O
(	O
Southern	O
Biotech	O
),	O
they	O
were	O
imaged	O
by	O
confocal	O
microscopy	O
(	O
Zeiss	O
LSM	O
710	O
Imager	O
Z2	O
laser	O
scanning	O
confocal	O
microscope	O
,	O
Zen	O
2009	O
software	O
).	O

To	O
assess	O
the	O
efficiency	O
of	O
the	O
AAV	B-OG
-	O
mediated	O
knockdown	O
,	O
Alexa	O
Fluor	O
568	O
tagged	O
NDUFS4	B-GP
expression	O
(	O
red	O
immunofluorescence	O
)	O
was	O
quantified	O
in	O
the	O
virus	B-OG
infected	O
cells	O
which	O
co	O
-	O
expressed	O
the	O
Green	B-GP
Fluorescent	I-GP
Protein	I-GP
(	O
GFP	B-GP
,	O
Alexa	O
Fluor	O
488	O
tagged	O
,	O
green	O
immunofluorescence	O
),	O
and	O
expressed	O
as	O
a	O
percentage	O
of	O
total	O
infected	O
cells	O
.	O

20	O
image	O
fields	O
were	O
quantified	O
per	O
injected	O
locus	O
.	O

These	O
were	O
from	O
5	O
bilateral	O
alternating	O
slices	O
,	O
4	O
image	O
fields	O
per	O
slice	O
,	O
of	O
85μmX85μm	O
size	O
each	O
,	O
quantified	O
by	O
a	O
blinded	O
scorer	O
.	O

Field	O
potential	O
recordings	O

Field	O
potential	O
experiments	O
were	O
performed	O
as	O
described	O
previously	O
with	O
modifications	O
[	O
9	O
].	O

Briefly	O
,	O
400	O
μm	O
thick	O
sagittal	O
slices	O
of	O
the	O
mouse	B-OG
brain	O
were	O
collected	O
.	O

The	O
recording	O
electrode	O
was	O
placed	O
in	O
parietal	O
association	O
cortex	O
and	O
the	O
stimulation	O
electrode	O
was	O
positioned	O
~	O
1mm	O
rostrally	O
in	O
the	O
cortex	O
.	O

The	O
amplitude	O
was	O
selected	O
to	O
produce	O
half	O
-	O
maximal	O
fEPSP	O
amplitude	O
.	O

The	O
stimulus	O
duration	O
was	O
100	O
μs	O
.	O

Field	O
potential	O
signals	O
were	O
amplified	O
using	O
EPC10	O
amplifier	O
(	O
HEKA	O
)	O
and	O
digitized	O
with	O
Digidata	O
1322A	O
(	O
Axon	O
Instruments	O
)	O
at	O
250	O
kHz	O
sampling	O
rate	O
.	O

Stimulations	O
were	O
applied	O
at	O
0	O
.	O
033	O
Hz	O
.	O

Isoflurane	O
was	O
applied	O
in	O
the	O
superfusate	O
at	O
equilibrated	O
concentrations	O
delivered	O
by	O
passing	O
carbogen	O
through	O
a	O
calibrated	O
isoflurane	O
vaporizer	O
(	O
Scivena	O
Scientific	O
TEC	O
-	O
3	O
and	O
Patterson	O
Veterinary	O
TEC	O
-	O
3	O
).	O

Amplitudes	O
of	O
fEPSPs	O
and	O
FVs	O
were	O
normalized	O
to	O
their	O
respective	O
averages	O
during	O
the	O
last	O
5	O
min	O
prior	O
to	O
isoflurane	O
exposure	O
for	O
each	O
individual	O
recording	O
.	O

Statistical	O
analyses	O

A	O
statistical	O
power	O
analysis	O
was	O
performed	O
using	O
the	O
control	O
values	O
and	O
standard	O
deviation	O
for	O
the	O
uninjected	O
control	O
mice	B-OG
as	O
reference	O
.	O

Specifying	O
an	O
effect	O
size	O
of	O
0	O
.	O
25	O
,	O
α	O
of	O
0	O
.	O
05	O
and	O
power	O
of	O
0	O
.	O
8	O
for	O
each	O
assay	O
(	O
LORR	O
-	O
ISO	O
,	O
LORR	O
-	O
HAL	O
,	O
TC	O
-	O
ISO	O
and	O
TC	O
-	O
HAL	O
),	O
we	O
found	O
the	O
minimal	O
sample	O
size	O
to	O
be	O
2	O
.	O

For	O
all	O
region	O
-	O
specific	O
injections	O
,	O
we	O
used	O
a	O
minimal	O
cohort	O
size	O
of	O
6	O
per	O
category	O
.	O

The	O
effective	O
concentration	O
for	O
50	O
%	O
of	O
the	O
animals	B-OG
tested	O
(	O
EC50	O
)	O
for	O
each	O
volatile	O
anesthetic	O
was	O
determined	O
as	O
described	O
by	O
Sonner	O
et	O
al	O
.	O
[	O
62	O
],	O
using	O
an	O
up	O
and	O
down	O
method	O
.	O

Values	O
for	O
EC50s	O
were	O
compared	O
between	O
the	O
WT	O
and	O
regional	O
KD	O
strains	O
by	O
Student	O
’	O
s	O
t	O
-	O
test	O
using	O
GraphPad	O
Prism	O
®.	O

For	O
the	O
electrophysiological	O
field	O
recordings	O
,	O
values	O
for	O
fEPSPs	O
and	O
fiber	O
volleys	O
for	O
slices	O
(	O
n	O
=	O
7	O
for	O
control	O
,	O
n	O
=	O
6	O
for	O
Ndufs4	B-GP
(	O
KO	O
))	O
were	O
averaged	O
and	O
significance	O
analyzed	O
by	O
one	O
-	O
way	O
ANOVA	O
using	O
GraphPad	O
Prism	O
®.	O

Significance	O
was	O
defined	O
as	O
a	O
p	O
<	O
0	O
.	O
01	O
.	O

Supporting	O
information	O

Loss	O
of	O
NDUFS4	B-GP
in	O
the	O
PAC	O
.	O

Unmerged	O
and	O
merged	O
confocal	O
images	O
of	O
the	O
(	O
A	O
)	O
Δ	O
–	O
Cre	B-GP
injected	O
and	O
(	O
B	O
)	O
WT	O
-	O
Cre	B-GP
injected	O
PAC	O
(	O
Magnification	O
X1000	O
).	O

White	O
arrows	O
point	O
to	O
cells	O
which	O
retained	O
the	O
red	O
NDUFS4	B-GP
fluorescence	O
in	O
the	O
absence	O
of	O
virus	B-DS
infection	I-DS
.	O

Scale	O
bar	O
:	O
10μm	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Cytochrome	B-GP
C	I-GP
immunostaining	O
in	O
the	O
virus	B-OG
injected	O
regions	O
.	O

Unmerged	O
and	O
merged	O
confocal	O
images	O
of	O
the	O
(	O
A	O
)	O
Δ	O
–	O
Cre	B-GP
injected	O
and	O
(	O
B	O
)	O
WT	O
-	O
Cre	B-GP
injected	O
VN	O
(	O
Magnification	O
X1000	O
).	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Fluorescent	O
images	O
of	O
brain	O
slices	O
from	O
mice	B-OG
injected	O
with	O
inactive	O
Δ	O
-	O
Cre	B-GP
virus	B-OG
into	O
the	O
(	O
A	O
)	O
VN	O
,	O
(	O
B	O
)	O
MPTA	O
,	O
(	O
C	O
)	O
CMT	O
,	O
(	O
D	O
)	O
DMT	O
and	O
(	O
E	O
)	O
PAC	O
(	O
Magnification	O
X40	O
).	O

Scale	O
bar	O
:	O
1mm	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Scatter	O
plots	O
showing	O
individual	O
EC50	O
values	O
using	O
ISO	O
and	O
HAL	O
for	O
LORR	O
and	O
TC	O
in	O
the	O
vestibular	O
nucleus	O
(	O
VN	O
),	O
mesopontine	O
tegmental	O
anesthetic	O
area	O
(	O
MPTA	O
),	O
central	O
medial	O
thalamus	O
(	O
CMT	O
),	O
dorsal	O
medial	O
thalamus	O
(	O
DMT	O
)	O
and	O
parietal	O
association	O
cortex	O
(	O
PAC	O
).	O

Large	O
cross	O
bars	O
represent	O
the	O
mean	O
of	O
EC50s	O
for	O
ISO	O
(	O
red	O
dots	O
)	O
and	O
HAL	O
(	O
black	O
dots	O
)	O
for	O
the	O
WT	O
-	O
Cre	B-GP
(	O
KD	O
)	O
and	O
Δ	O
-	O
Cre	B-GP
(	O
Control	O
)	O
virus	B-OG
-	O
injected	O
mice	B-OG
in	O
the	O
LORR	O
and	O
TC	O
assays	O
.	O

Small	O
crossbars	O
represent	O
the	O
standard	O
error	O
of	O
the	O
mean	O
.	O

Plots	O
depict	O
viral	O
injections	O
performed	O
into	O
the	O
VN	O
(	O
A	O
&	O
B	O
,	O
Control	O
n	O
=	O
6	O
,	O
KD	O
n	O
=	O
7	O
),	O
MPTA	O
(	O
C	O
&	O
D	O
,	O
Control	O
n	O
=	O
7	O
,	O
KD	O
n	O
=	O
6	O
),	O
CMT	O
(	O
E	O
&	O
F	O
,	O
n	O
=	O
6	O
for	O
Control	O
and	O
KD	O
),	O
DMT	O
(	O
G	O
&	O
H	O
,	O
n	O
=	O
6	O
for	O
Control	O
and	O
KD	O
)	O
and	O
PAC	O
(	O
I	O
&	O
J	O
,	O
n	O
=	O
6	O
for	O
Control	O
and	O
KD	O
).	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

EC50s	O
for	O
ISO	O
and	O
HAL	O
for	O
the	O
the	O
global	O
KO	O
and	O
control	O
mice	B-OG
in	O
the	O
LORR	O
assay	O
.	O

Previously	O
published	O
data	O
for	O
the	O
TC	O
assay	O
[	O
3	O
]	O
are	O
included	O
for	O
comparison	O
.	O

(	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Viral	O
injection	O
coordinates	O
and	O
quantities	O
.	O

(	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

